BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26830028)

  • 1. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
    Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
    Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.
    Terada T
    Pathol Res Pract; 2010 Jun; 206(6):420-5. PubMed ID: 20189318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine-nonneuroendocrine neoplasm.
    Sun L; Zhang J; Wang C; Zhao S; Shao B; Guo Y; Liu Y; Sun Y
    Mod Pathol; 2020 Dec; 33(12):2602-2613. PubMed ID: 32461621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
    Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
    World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
    Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.
    Busca A; Djordjevic B; Giassi A; Parra-Herran C
    Am J Clin Pathol; 2016 Apr; 145(4):486-96. PubMed ID: 27124937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
    Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
    Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations of p-AKT with PTEN, P53, HER-2 expressions in endometrial carcinoma and their relationship with patient survival].
    Zhang XM; Liang Y; Dong Y; Zhang Y; Wang Y; Meng YT; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):135-41. PubMed ID: 22353917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.
    Minaguchi T; Nakagawa S; Takazawa Y; Nei T; Horie K; Fujiwara T; Osuga Y; Yasugi T; Kugu K; Yano T; Yoshikawa H; Taketani Y
    Cancer Lett; 2007 Apr; 248(1):112-22. PubMed ID: 16919866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
    Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
    Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed large and small cell neuroendocrine carcinoma of the endometrium with serous carcinoma: A case report and literature review.
    Hu R; Jiang J; Song G; Zhu C; Chen L; Wang C; Wang X
    Medicine (Baltimore); 2019 Jul; 98(29):e16433. PubMed ID: 31335697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
    Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
    Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
    Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.
    Wang G; Huang H; Kamat AM; Siefker-Radtke A; Dinney CP; Troncoso P; Czerniak B; Guo CC
    Hum Pathol; 2017 Sep; 67():126-133. PubMed ID: 28823575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
    McCluggage WG; Sumathi VP; Maxwell P
    Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.